Utility of targeted glucocorticoids in cancer therapy

Manuela Banciu1, Raymond M Schiffelers, Josbert M Metselaar

  • 1Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Insights

Glucocorticoids can inhibit solid tumor growth by reducing inflammation and angiogenesis. Research is exploring targeted delivery systems, with long-circulating liposomes showing promise for cancer therapy.

Area of Science:

  • Oncology
  • Pharmacology
  • Immunology

Background:

  • Glucocorticoids possess anti-tumor properties by suppressing inflammation and angiogenesis.
  • Solid tumors often exhibit inflammation and angiogenesis, which are crucial for their growth.

Purpose of the Study:

  • To review the mechanisms by which glucocorticoids inhibit tumor growth.
  • To provide an overview of current tumor-targeted glucocorticoid delivery strategies.

Main Methods:

  • Literature review of glucocorticoid mechanisms in cancer.
  • Survey of existing and emerging targeted drug delivery systems for glucocorticoids.

Main Results:

  • Glucocorticoids inhibit tumor growth through downregulation of inflammation and angiogenesis.
  • Long-circulating liposomes are the primary delivery system currently under investigation for targeted glucocorticoid therapy.

Conclusions:

  • Glucocorticoids represent a potential therapeutic strategy for solid tumors.
  • Targeted delivery, particularly using liposomes, is essential for optimizing glucocorticoid efficacy and minimizing side effects in cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...